Traders work on the floor of the New York Stock Exchange   in New York . Photographer: Michael Nagle/Bloomberg

World stock markets climbed on Monday, lifted by optimism over the outlook for corporate earnings and US president Donald Trump’s tax reform plan, wh(...)

Novartis estimates that only 600 patients a year would be eligible for its new $375,000 therapy. Photograph: Vivek Prakash/Reuters

Novartis’s new gene-modifying cancer therapy’s $475,000 (€399,100) per patient sticker price has drawn fire from advocate groups calling for cheaper d(...)

An IV bag of Novartis drug, Kymriah. Photograph: AP

Swiss pharmaceuticals group Novartis has said it will charge $475,000 (€400,000) a patient for its new cancer therapy, putting it among the most expen(...)

In the US, uncertainty about the impact of tropical storm Harvey pushed investors toward safe-haven assets. Photographer: Michael Nagle/Bloomberg

Sterling-sensitive stocks such as C&C, Total Produce and Bank of Ireland were out of sorts on Monday in Dublin as the UK currency continued its lo(...)

PrEP   is not covered by the HSE. It costs €400 a month to buy it privately with a doctor’s prescription.

A revolutionary anti-HIV drug may not be available under the HSE payment scheme until 2019, a delay that could see up to 800 new infections, health gr(...)

The original European patent on Truvada is due to expire this year

Customs are intercepting and seizing large amounts of a revolutionary anti- HIV drug which is being ordered by people online. Pre-Exposure Proph(...)

Pfizer will offer Medivation shareholders $81.50 per share in cash, a premium of 21.35 percent to the stock’s Friday close of $67.16.

Pfizer, which employs about 3,200 people at six sites in Ireland, is to buy US cancer drug company Medivation Inc in a deal valued at about $14 billio(...)

The headquarters of Nestlé’s French section in the old Meunier chocolate factory: the company’s stocks rose 3.3 per cent after naming Ulf Mark Schneider as  chief executive officer. Photograph: Thomas  Samson/AFP/Getty Images

European shares rose for the first time in three days yesterday after a heavy sell-off following Britain’s shock vote to leave the European Union, wit(...)

 Sovaldi, a once-a-day prescription medicine used to treat hepatitis C. Manufacturer Gilead Sciences is working out how to bring the drug, which infamously retails in the US at $1,000 a pill, for relatively next to nothing to low income countries around the world.

Gregg Alton has what seems like a disorienting job at Gilead Sciences. He’s paid to figure out how to sell the drug Sovaldi, which infamously re(...)

Ryanair CEO Michael O’Leary: results due Monday. Photograph:  EPA/OLIVIER HOSLET
For your diary

TODAY Results: Alphabet; Bankia; LG; Ryanair; Universal. Indicators: Irish Investec manufacturing PMI (Jan); German Markit manufacturing PMI (Jan); eu(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last »